Scienture Holdings, Inc. Announces Participation in The Microcap Conference 2025
17. Dezember 2024 08:05 ET
|
Scienture Holdings, Inc.
TAMPA, FL, Dec. 17, 2024 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (the “Company”) (NASDAQ: SCNX), a specialty pharma company with a novel pipeline of brand products, is pleased to announce its...
Medexus présente une déclaration d’acquisition
07. Januar 2019 14:35 ET
|
Medexus Pharmaceuticals Inc.
MONTRÉAL, 07 janv. 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (anciennement Pediapharm Inc.) (la « Société ») (TSXV : MDP, OTCQB : PDDPF) a annoncé aujourd’hui la présentation d’une...
Medexus Files Business Acquisition Report
07. Januar 2019 14:35 ET
|
Medexus Pharmaceuticals Inc.
MONTREAL, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) (the “Company”) (TSXV: MDP, OTCQB: PDDPF) today announced the filing of the Business Acquisition...
Medexus Announces New Chief Executive Officer, Chair of the Board of Directors, Other Organizational Updates and Equity Incentive Grants
17. Dezember 2018 14:30 ET
|
Medexus Pharmaceuticals Inc.
MONTREAL, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) (the “Company”) (TSXV: PDP, OTCQB: PDDPF) today announced organizational changes designed to...
Pediapharm Announces Name Change, Consolidation and Debenture Repayment
13. Dezember 2018 15:44 ET
|
Medexus Pharmaceuticals Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. ...
Pediapharm annonce les résultats de son deuxième trimestre – BAIIA ajusté record, ventes records et un 13e trimestre consécutif de croissance d’un exercice à l’autre
27. November 2018 08:00 ET
|
Pediapharm Inc.
CE COMMUNIQUÉ NE PEUT ÊTRE DISTRIBUÉ AUX AGENCES DE TRANSMISSION AMÉRICAINES NI DIFFUSÉ AUX ÉTATS-UNIS. NE PAS RESPECTER CETTE CONSIGNE PEUT CONSTITUER UNE VIOLATION DE LA LOI SUR LES TITRES DES...
Pediapharm Announces Q2 Results – Record Adjusted EBITDA, Record Revenue and 13th Consecutive Year-Over-Year Quarterly Revenue Growth
27. November 2018 08:00 ET
|
Pediapharm Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. ...
Pediapharm Announces Closing of Transformative Acquisitions, Diversifying and Expanding the Platform for Future Growth
16. Oktober 2018 17:12 ET
|
Pediapharm Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. ...
Pediapharm Announces Closing of Subscription Receipt Offering for Total Gross Proceeds of $62 Million
11. Oktober 2018 12:14 ET
|
Pediapharm Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. ...
Pediapharm Files Corporate Presentation
12. September 2018 15:17 ET
|
Pediapharm Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. ...